Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.

 
Web www.patentalert.com

< Inducible alphaviral gene expression system

< Peptide and osteogenetic accelerator

> Colon cleansing composition and method

> Enzymes coated with ionic liquid

~ 00242